But that is not what is happening. Major pharmaceuticals are increasingly looking outside their in-house labs to find promising drugs. In fact, 50 percent of their drugs now under development were created by smaller outside companies. In these cases, the focus of the smaller company translates into greater agility and ability to specialize that big companies lack.
Moreover, scientists and entrepreneurs who have developed new drugs feel a personal connection with their creations which aids in their success. This essential human element gives dynamism to an economy and should be encouraged. The heart and soul of economy is found much more in these human factors than in the empirical data and index quotes that dominate business pages.